Houston Methodist Sugar Land Hospital

Medicine & Life Sciences

1. Liver Transplantation 100%
2. Neoplasms 40%
3. Transplant Recipients 39%
4. Autologous Transplantation 36%
5. Carcinoma, Intraductal, Noninfiltrating 33%
6. Heart Neoplasms 31%
7. Therapeutics 30%
8. Hyperglycemia 27%
9. Breast Neoplasms 27%
10. Colorectal Surgery 26%
11. Mononeuropathies 26%
12. Parkinson Disease 26%
13. Xylazine 26%
14. Ovarian Neoplasms 25%
15. Femoral Nerve 25%
16. Spine 24%
17. Neoadjuvant Therapy 24%
18. Brain Concussion 23%
19. Trypanosoma 23%
20. Coronavirus 23%
21. Hepatocellular Carcinoma 22%
22. Triple Negative Breast Neoplasms 22%
23. Wounds and Injuries 22%
24. Deep Brain Stimulation 21%
25. Cholangiocarcinoma 21%
26. Segmental Mastectomy 21%
27. Neoplasm Metastasis 21%
28. Transplants 21%
29. Ketamine 20%
30. Insulin 20%
31. Sarcoma 20%
32. Spinal Fusion 20%
33. Population 19%
34. Nitric Oxide Synthase Type II 19%
35. catalase HPI 19%
36. Veterans 19%
37. Radiotherapy 19%
38. Tomography 19%
39. Critical Illness 19%
40. INK128 18%
41. Trypanosoma brucei brucei 18%
42. Mortality 18%
43. Lower Extremity 17%
44. Kidney Transplantation 17%
45. Heart 17%
46. Drug Therapy 17%
47. Bariatric Surgery 17%
48. Surgeons 17%
49. alvimopan 17%
50. Forelimb 16%
51. End Stage Liver Disease 16%
52. Decision Making 16%
53. Transanal Endoscopic Surgery 16%
54. Psychology 16%
55. Cognition 16%
56. Receptor, Fibroblast Growth Factor, Type 4 16%
57. 2003-2011 Iraq War 16%
58. Loeys-Dietz Syndrome 15%
59. Guidelines 15%
60. cangrelor 15%
61. Melanoma 15%
62. Surgical Tape 15%
63. Immunotherapy 15%
64. Ado-Trastuzumab Emtansine 15%
65. Glucose 15%
66. Abdominal Pain 15%
67. Colectomy 15%
68. SARS Virus 15%
69. Ileus 14%
70. Extremities 14%
71. Histiocytic Necrotizing Lymphadenitis 14%
72. pertuzumab 14%
73. Transplantation 14%
74. 130-nm albumin-bound paclitaxel 14%
75. Ulnar Collateral Ligament 14%
76. Lipopolysaccharides 14%
77. Drug Hypersensitivity Syndrome 14%
78. Everolimus 14%
79. Memory 14%
80. Costs and Cost Analysis 14%
81. Shoulder 14%
82. Pediatrics 14%
83. CJ 21058 14%
84. Versicans 14%
85. Inpatients 13%
86. Heart Rupture 13%
87. Immune Reconstitution Inflammatory Syndrome 13%
88. Endotoxemia 13%
89. Peripheral Nervous System 13%
90. taxane 13%
91. Seat Belts 13%
92. Safety 13%
93. Recurrence 13%
94. Lapatinib 13%
95. Minimally Invasive Surgical Procedures 13%
96. Technetium Tc 99m Medronate 13%
97. Pain 13%
98. Medical Futility 13%
99. Students 13%
100. Cancer-Associated Fibroblasts 13%